Osimertinib in First Line What About Second Line Treatment

Osimertinib in First Line What About Second Line Treatment

thoraciconcology

2 years
209 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Charles Rudin, MD, PhD of Memorial Sloan Kettering Cancer Center talks about using Osimertinib in first line and possible shift to old practice afterwards. Osimertinib with positive data in the first line setting is very promising. Although FDA approval for Osimertinib is still pending, doctors can shift now to using it in the front-line setting based on the NCCN guidelines.

This is already been adapted and according to available data, Osimertinib is a superior drug. So, the question now would be on what to use in the second and third line setting. Dr. Rudin said that patients might end up going back to the traditional first-line therapy - platinum-based doublet chemotherapy.
Up Next Autoplay